Fortis Healthcare Q2 FY27 Revenue at ₹2,735 Cr, Up 17.3%; Acquires Suguna Hospital
Fortis Healthcare reported Q2 FY27 consolidated revenues of ₹2,735 crore, up 17.3% YoY. Hospital revenues grew 18.6% to ₹2,340 crore, and diagnostics revenues rose 12.2% to ₹448 crore. The company acquired Suguna Hospital in Bengaluru and will provide services for a new 400+ bed hospital in New Delhi.
The announcement includes significant financial results with double-digit growth and key strategic inorganic growth initiatives like acquisitions and new hospital development, which are expected to have a substantial impact on the company's future performance and market position.
The company reported strong year-on-year revenue growth in both its hospital and diagnostics businesses, along with strategic acquisitions and partnerships that are expected to drive future growth.
Fortis Healthcare Limited announced its unaudited consolidated financial results for the quarter and half year ended September 30, 2026. Consolidated revenues for Q2 FY27 reached ₹2,735 crore, marking a 17.3% increase year-on-year, with a Profit After Tax (PAT) margin of 11.7%.
The hospital business reported revenues of ₹2,340 crore for Q2 FY27, an 18.6% rise year-on-year, while the diagnostics business saw gross revenues of ₹448 crore, up 12.2%.
In terms of strategic developments, Fortis, through its subsidiary Fortis Hospotel Limited, has entered into agreements to provide healthcare services for a new 400+ bedded super-specialty hospital in Ashok Vihar, New Delhi, expected to commence operations in 3-4 years. Additionally, through its subsidiary International Hospitals Limited, Fortis acquired Suguna Hospital, a 110-bedded facility in Rajajinagar, Bengaluru, with potential for expansion to approximately 150 beds.
Dr. Ashutosh Raghuvanshi, MD and CEO of Fortis Healthcare, commented on the sustained growth across both hospital and diagnostics businesses, highlighting the strengthening of clinical capabilities and expansion in key markets. He noted the acquisition of Suguna Hospital and the agreement for the New Delhi hospital as significant steps in reinforcing their presence in Bengaluru and Delhi NCR clusters, respectively. The diagnostics business also demonstrated consistent growth and strong operational momentum, with ongoing capacity expansion and a focus on clinical excellence.
What to do with a filing like this
Fortis Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Fortis Healthcare Limited. Read the original for the full detail.